

Dr. Padraic O'Malley
Urologic Oncologist
1 Podcast on BackTable
Dr. Pedraic O'Malley is an associate professor and the chief of urologic oncology at University of Florida in Gainesville.
Learn from the experiences and expertise of Dr. Padraic O'Malley and other leading voices in your specialty on the BackTable app.

Episode # 143 • 20 Dec 2023
Navigating Upper Tract Urothelial Carcinoma
In this episode, host Dr. Jose Silva and Dr. Padraic O’Malley, a urologic oncologist from University of Florida Health, discuss how to diagnose and treat upper tract urothelial carcinoma.
More from Dr. Padraic O'Malley
About
Dr. Padraic O’Malley, MSc, MD, FRCSC, is a Clinical Assistant Professor in the University of Florida Department of Urology and serves as Chief of Urologic Oncology. He earned his medical degree from Saba University School of Medicine and completed his urology residency at the University of Toronto in Toronto, Canada, where he received the Undergraduate Teaching Award. He subsequently completed a fellowship in urologic oncology at Weill-Cornell Medical College in New York, New York, where he was honored with the Ferdinand C. Valentine Fellowship Award. Since joining UF Health in 2018, Dr. O’Malley has been recognized with the UF College of Medicine Exemplary Teacher Award and the Department of Urology Rising Star Award.
Dr. O’Malley currently serves as a board member of the Florida Urological Society and the Southeastern Section of the American Urological Association. He is also a member of the American Urological Association, the Canadian Urological Association, the Endourological Society, and the Society of Urologic Oncology, and is an international member of the European Association of Urology. In addition to his clinical and teaching responsibilities, he has authored numerous urology-focused publications, book chapters, and abstracts.
His clinical expertise centers on urologic oncology, multidisciplinary care, and robotic surgical techniques. Dr. O’Malley performs complex robotic procedures, with particular expertise in bladder and kidney cancer. His work includes the management of IVC thrombus, robotic and open tumor thrombectomies, and both robotic and open retroperitoneal lymph node dissections. He serves as a sub-investigator on multiple clinical trials focused on bladder, kidney, and prostate cancer. His research interests include studying the tumor microenvironment in bladder and kidney cancer, exploring novel nanoparticle and artificial intelligence–based analysis of exosome-driven multi-fluid multi-omics in bladder cancer, and investigating the role of surgery in advanced kidney cancer.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.